ArticleJournal of immunology research2022

Pan-Cancer Analysis of B4GALNT1 as a Potential Prognostic and Immunological Biomarker.

Hang Yi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.